|
시장보고서
상품코드
2039099
병원내감염 검사 시장 : 검사 유형별, 지역별Hospital-Acquired Disease Testing Market, By Test Type, By Geography |
||||||
병원내감염 검사 시장은 2026년에 186억 달러로 추정되며, 2033년까지 494억 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 15.5%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 186억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 15.50% | 2033년 시장 규모 예측: | 494억 달러 |
병원내감염은 의료 서비스를 받는 환자가 감염되는 것을 말합니다. 가장 흔한 병원내감염에는 요로 감염, 혈류 감염, 메티실린 내성 황색포도상구균(MRSA), 폐렴구균 감염, 위장병 등이 있습니다. 전 세계적으로 병원내감염과 관련된 이환율이 증가하고 있는 것이 병원내감염 검사 시장의 성장을 이끄는 주요 요인으로 작용하고 있습니다. 현대 의료시설에서 사용되는 카테터, 인공호흡기 등 의료기기도 이러한 감염의 주요 원인 중 하나입니다.
시장 역학
시장 주요 기업들은 병원내감염 검사 시장에서 제품 포트폴리오와 세계 입지를 확대하기 위해 인수합병, 제휴, 파트너십과 같은 확장 전략을 채택하는 데 주력하고 있습니다. 예를 들어, 2019년 4월 Meridian Bioscience, Inc.는 캐나다에 본사를 둔 분자진단 기기 및 분석 업체인 GenePOC Inc.를 인수하는 계약을 체결했습니다. 이번 인수를 통해 메리디안 바이오사이언스는 GenePOC의 최첨단 Revogene 분자진단 플랫폼을 자사의 진단 포트폴리오에 통합하게 됩니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략 및 향후 계획과 같은 매개 변수를 기반으로 전 세계 병원내감염 검사 시장의 주요 기업을 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 병원내감염 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 병원내감염 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 병원내감염 검사 시장 : 검사 유형별, 2026-2033년
제5장 세계의 병원내감염 검사 시장 : 지역별, 2026-2033년
제6장 경쟁 구도
제7장 섹션
KSM 26.06.04Hospital-Acquired Disease Testing Market is estimated to be valued at USD 18.6 Bn in 2026 and is expected to reach USD 49.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.50% | 2033 Value Projection: | USD 49.4 Bn |
Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is a major factor driving the growth of the hospital-acquired disease testing market. Devices such as catheters and ventilators that are used in modern care facilities are also among the primary causes of these infections.
Market Dynamics
Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships in order to expand their product portfolio and global presence in the hospital-acquired disease testing market. For instance, in April 2019, Meridian Bioscience, Inc. entered an agreement to acquire GenePOC Inc., a Canada based provider of molecular diagnostic instruments and assays. Through this acquisition, Meridian Bioscience will include state-of-the art revogene molecular diagnostics platform of GenePOC Inc. in its diagnostics portfolio.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global hospital-acquired disease testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Luminex Corporation, Diatherix laboratories, Life technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomerieux, and Cepheid.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product Type up-gradation, market expansion, and marketing tactics
- The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital-acquired disease testing market
Market Segmentation
- By Test Type
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Luminex Corporation
- Diatherix Laboratories
- Life Technologies
- Cantel Medical Corporation
- Meridian Biosciences Inc
- Nordion Inc
- Qiagen GmbH
- Hoffmann-La Roche Ltd.
- Biomerieux
- Cepheid
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Hospital-Acquired Disease Testing Market, By Test Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Surgical Site Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Pneumonia Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Blood Stream Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
5. Global Hospital-Acquired Disease Testing Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
6. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Diatherix Laboratories
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Life Technologies
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cantel Medical Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Meridian Biosciences Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Nordion Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Qiagen GmbH
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Biomerieux
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
7. Section
- References
- Research Methodology
- About Us
